GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Givaudan SA (OTCPK:GVDNY) » Definitions » Other Income (Expense)

Givaudan (Givaudan) Other Income (Expense) : $9 Mil (TTM As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Givaudan Other Income (Expense)?

Givaudan's other income expense for the Givaudan's pretax income for the six months ended in Dec. 2023 was $10 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was $9 Mil.


Givaudan Other Income (Expense) Historical Data

The historical data trend for Givaudan's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Givaudan Other Income (Expense) Chart

Givaudan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -43.76 -58.53 -33.66 -84.80 9.25

Givaudan Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.92 -67.00 -15.03 -1.11 10.41

Givaudan Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Givaudan  (OTCPK:GVDNY) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Givaudan (Givaudan) Business Description

Address
Chemin de la Parfumerie 5, Vernier, CHE, 1214
Spun off from Roche in 2000, Givaudan is one of the world's leading flavour and fragrance manufacturers, with a presence in more than 80 countries. It sources more than 10,000 different ingredients from 100 countries. The company serves end consumer markets with fragrances for personal-, home-, and laundry-care brands, including prestige perfumes. In flavours, customers are in beverages, savoury, snacks, sweet goods, and dairy. Givaudan has nearly 10,000 employees, and its perfumery team is the largest in the industry.

Givaudan (Givaudan) Headlines

From GuruFocus

Full Year 2022 Givaudan SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Full Year 2021 Givaudan SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Half Year 2021 Givaudan SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Full Year 2019 Givaudan SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Full Year 2022 Givaudan SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Full Year 2021 Givaudan SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Full Year 2020 Givaudan SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Half Year 2019 Givaudan SA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Full Year 2023 Givaudan SA Earnings Call Transcript

By GuruFocus Research 02-13-2024